Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hypertension Diagnostics Inc (HDII) -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (2)	4/27/2000 7:03:00 AM
From: scott_jiminez	Respond to of 120

Guess we'll (I'll ??) just have to wait and see how this plays out. The headline is juuuuussst a little bit distracting since, in addition to being a director of the company....Sellke was also the CEO. Guess we'll be reading 'page 2' in the coming months. >>>>>>>>>>>>>> Hypertension Diagnostics Announces Resignation of Director ST. PAUL, Minn., April 26 /PRNewswire/ -- Hypertension Diagnostics, Inc. (Nasdaq: HDII - news, HDIIW - news, HDIIU - news), announced today that Dennis L. Sellke has resigned as a director of the Company effective April 21, 2000, and will no longer be serving as its Chief Executive Officer. ``We regretfully accept Dennis' resignation. During his tenure, the Company has made significant progress. The Company wishes him well in his future business endeavors,'' said Melville R. Bois, the Company's Chairman. The Company also reported that Greg H. Guettler, the Company's President, would assume most of Mr. Sellke's responsibilities with the assistance of the other Company officers, Dr. Charles F. Chesney, Executive Vice President and Chief Technology Officer, and Mr. James S. Murphy, Senior Vice President of Finance & Administration and Chief Financial Officer. <background & SEC warnings deleted> <<<<<<<<<<